drugset / Trial / NCT01554683

Seizure Activity in Alzheimer's Disease

NCT01554683

Completed 12 enrolled Beth Israel Deaconess Medical Center
RandomizedCrossoverDouble-blindBasic science

Summary

The main purpose of this research project is to study how seizure-like activity affects the blood flow in the brain of patients with Alzheimer's disease (AD). Changes in blood flow can change memory and thinking ability, as happens in Alzheimer's disease. The investigators are using a study drug called Levetiracetam, which helps control seizure-like activity to see if it can help change the abnormal blood flow in the brain that is seen in some people with Alzheimer's disease.

Timeline

Start
2012-02
Primary completion
2017-07-01
Completion
2017-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 2.5 mg/kg Intravenous
Comparator Levetiracetam Other / unclassified 7.5 mg/kg Intravenous